首页 > 最新文献

Bioimpacts最新文献

英文 中文
Chondrogenic potential of PMSCs cultured on chondroitin sulfate/gelatin-modified DBM scaffold. 硫酸软骨素/明胶修饰DBM支架培养PMSCs的成软骨潜能。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-27 eCollection Date: 2025-01-01 DOI: 10.34172/bi.2023.30003
Fatemeh Haghwerdi, Ismaeil Haririan, Masoud Soleimani

Introduction: Osteoarthritis is one of the most common orthopedic diseases that gradually causes wear and damage to the articular Subchondral bone due to the destruction of articular cartilage. One of the basic challenges in cartilage tissue engineering is the choice of scaffold. In the design of the cartilage scaffold, it is useful to consider parameters such as porosity, water absorption, high mechanical resistance, biocompatibility, and biodegradability. Therefore, in this study, demineralized bone matrix (DBM), which inherently has these characteristics to some extent, was chosen as the basic scaffold.

Methods: The gelatin/DBM (G/DBM) and the chondroitin sulfate-gelatin/DBM (GCS/DBM) scaffolds were prepared, respectively, by incorporating gelatin or chondroitin sulfate/gelatin solution inside DBM pores, freeze-drying and crosslinking with EDC/NHS. The physicochemical, biological characteristics and chondrogenic potential of scaffolds were studied.

Results: According to the SEM results, the size of the DBM pores in the G/DBM and GCS/DBM scaffolds decreased (from almost 100-1500 µm to less than 200 µm), which reduced cell escape compared to the DBM scaffold. Also, crosslinking the scaffolds has greatly increased their compressive E-modulus (more than 8 times). The cytocompatibility and non- toxicity of all scaffolds were confirmed by acridine orange/ethidium bromide (AO/EB) staining. The evaluation results of chondrogenic differentiation of placenta-derived mesenchymal stem cells (PMSCs) on modified scaffolds, using the real-time PCR method, showed that the presence of CS in the GCS/DBM scaffold improved the expression of chondrogenesis markers such as Aggrecan (AGC) (~4 times) and collagen 2 (COL-2) (~2.2 times) compared to the DBM scaffold. Also, Alcian blue staining and immunohistochemical analyses of the scaffolds showed denser and more coherent GAGs and COL-2 protein synthesis on the GCS/DBM than the G/DBM and DBM scaffolds.

Conclusion: According to the results, the GCS/DBM scaffold can be a suitable scaffold for cartilage tissue engineering.

骨关节炎是一种最常见的骨科疾病,由于关节软骨的破坏而逐渐引起关节软骨下骨的磨损和损伤。软骨组织工程的基本挑战之一是支架的选择。在软骨支架的设计中,考虑孔隙率、吸水性、高机械阻力、生物相容性和生物降解性等参数是有用的。因此,本研究选择在一定程度上具有这些特性的去矿化骨基质(demineralized bone matrix, DBM)作为基础支架。方法:将明胶或硫酸软骨素/明胶溶液掺入DBM孔内,冷冻干燥后与EDC/NHS交联,分别制备明胶/DBM (G/DBM)和硫酸软骨素-明胶/DBM (GCS/DBM)支架。研究了支架的理化、生物学特性和成软骨潜能。结果:SEM结果显示,与DBM支架相比,G/DBM和GCS/DBM支架中DBM孔的大小减小(从近100-1500µm降至200µm以下),减少了细胞逃逸。交联后支架的压缩e模量大大增加(超过8倍)。用吖啶橙/溴化乙啶(AO/EB)染色证实了支架的细胞相容性和无毒性。利用real-time PCR方法对改性支架上胎盘源间充质干细胞(PMSCs)的成软骨分化评价结果显示,与DBM支架相比,GCS/DBM支架中CS的存在使Aggrecan (AGC)和collagen 2 (COL-2)等成软骨标志物的表达提高了~4倍(~2.2倍)。阿利新蓝染色和免疫组织化学分析显示,GCS/DBM比G/DBM和DBM支架上的GAGs和COL-2蛋白合成更密集、更一致。结论:GCS/DBM支架是一种适合软骨组织工程的支架材料。
{"title":"Chondrogenic potential of PMSCs cultured on chondroitin sulfate/gelatin-modified DBM scaffold.","authors":"Fatemeh Haghwerdi, Ismaeil Haririan, Masoud Soleimani","doi":"10.34172/bi.2023.30003","DOIUrl":"10.34172/bi.2023.30003","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>Osteoarthritis is one of the most common orthopedic diseases that gradually causes wear and damage to the articular Subchondral bone due to the destruction of articular cartilage. One of the basic challenges in cartilage tissue engineering is the choice of scaffold. In the design of the cartilage scaffold, it is useful to consider parameters such as porosity, water absorption, high mechanical resistance, biocompatibility, and biodegradability. Therefore, in this study, demineralized bone matrix (DBM), which inherently has these characteristics to some extent, was chosen as the basic scaffold.</p><p><strong>Methods: </strong>The gelatin/DBM (G/DBM) and the chondroitin sulfate-gelatin/DBM (GCS/DBM) scaffolds were prepared, respectively, by incorporating gelatin or chondroitin sulfate/gelatin solution inside DBM pores, freeze-drying and crosslinking with EDC/NHS. The physicochemical, biological characteristics and chondrogenic potential of scaffolds were studied.</p><p><strong>Results: </strong>According to the SEM results, the size of the DBM pores in the G/DBM and GCS/DBM scaffolds decreased (from almost 100-1500 µm to less than 200 µm), which reduced cell escape compared to the DBM scaffold. Also, crosslinking the scaffolds has greatly increased their compressive E-modulus (more than 8 times). The cytocompatibility and non- toxicity of all scaffolds were confirmed by acridine orange/ethidium bromide (AO/EB) staining. The evaluation results of chondrogenic differentiation of placenta-derived mesenchymal stem cells (PMSCs) on modified scaffolds, using the real-time PCR method, showed that the presence of CS in the GCS/DBM scaffold improved the expression of chondrogenesis markers such as Aggrecan (AGC) (~4 times) and collagen 2 (COL-2) (~2.2 times) compared to the DBM scaffold. Also, Alcian blue staining and immunohistochemical analyses of the scaffolds showed denser and more coherent GAGs and COL-2 protein synthesis on the GCS/DBM than the G/DBM and DBM scaffolds.</p><p><strong>Conclusion: </strong>According to the results, the GCS/DBM scaffold can be a suitable scaffold for cartilage tissue engineering.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"15 ","pages":"30003"},"PeriodicalIF":2.2,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954754/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulation of ubiquitin-proteasome system and its relative pathways in pancreatic adenocarcinoma. 胰腺癌中泛素-蛋白酶体系统及其相关通路的调控。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-27 eCollection Date: 2025-01-01 DOI: 10.34172/bi.29993
Bahareh Shateri Amiri, Mehrasa Naserranjbar, AyAna Mirhaji, Alireza Hejrati, Lina Hejrati, Fatemeh Aliabadi

Introduction: Pancreatic cancer, which results from the uncontrolled growth of pancreatic cells, is the fourth most frequent cause of cancer-related mortality in the United States. About 90% of instances of pancreatic cancer are pancreatic adenocarcinomas, and occasionally "pancreatic cancer" is used exclusively to describe this subtype. Nab-paclitaxel, gemcitabine, and FOLFIRINOX are examples of modern chemotherapeutic drugs that have the ability to quickly confer resistance in pancreatic tumor cells. Therefore, in order to treat this dreadful condition, it is essential to develop more effective medicines. Inhibition of the ubiquitin-proteasome system (UPS) causes pancreatic cancer cells to die apoptotically. In eukaryotes, UPS is an essential mechanism for protein breakdown. Pancreatic cancer cells are more susceptible to endoplasmic reticulum stress (endoplasmic reticulum [ER] stress) and apoptosis when treated with bortezomib, a proteasome inhibitor that is the first in this group of drugs approved for the treatment of cancer, especially multiple myeloma.

Methods: Searching through PubMed and Google Scholar and gathering data.

Results: UPS is still a popular target for pancreatic cancer treatment among researchers. However, despite the favorable results of UPS-based therapies in vitro and in vivo, the clinical results are not as promising as expected.

Conclusion: A deep understanding of it, is essential to achieving the maximum results. In this review, we aim to look into the UPS along with searching for the novelist therapies for pancreatic adenocarcinoma based on manipulating it.

胰腺癌是由胰腺细胞不受控制的生长引起的,是美国癌症相关死亡的第四大常见原因。大约90%的胰腺癌是胰腺腺癌,偶尔“胰腺癌”被专门用来描述这种亚型。nab -紫杉醇、吉西他滨和FOLFIRINOX是现代化疗药物的例子,它们能够迅速赋予胰腺肿瘤细胞耐药性。因此,为了治疗这种可怕的疾病,开发更有效的药物是至关重要的。抑制泛素-蛋白酶体系统(UPS)导致胰腺癌细胞凋亡。在真核生物中,UPS是蛋白质分解的重要机制。硼替佐米是一种蛋白酶体抑制剂,是首个被批准用于治疗癌症,特别是多发性骨髓瘤的药物。方法:检索PubMed和谷歌Scholar,收集资料。结果:UPS仍然是研究人员对胰腺癌治疗的热门靶点。然而,尽管基于ups的治疗方法在体外和体内都取得了良好的结果,但临床结果并不像预期的那样有希望。结论:深刻理解它,是取得最大效果的关键。在这篇综述中,我们的目的是研究UPS,并在操纵它的基础上寻找治疗胰腺腺癌的新方法。
{"title":"Regulation of ubiquitin-proteasome system and its relative pathways in pancreatic adenocarcinoma.","authors":"Bahareh Shateri Amiri, Mehrasa Naserranjbar, AyAna Mirhaji, Alireza Hejrati, Lina Hejrati, Fatemeh Aliabadi","doi":"10.34172/bi.29993","DOIUrl":"10.34172/bi.29993","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>Pancreatic cancer, which results from the uncontrolled growth of pancreatic cells, is the fourth most frequent cause of cancer-related mortality in the United States. About 90% of instances of pancreatic cancer are pancreatic adenocarcinomas, and occasionally \"pancreatic cancer\" is used exclusively to describe this subtype. Nab-paclitaxel, gemcitabine, and FOLFIRINOX are examples of modern chemotherapeutic drugs that have the ability to quickly confer resistance in pancreatic tumor cells. Therefore, in order to treat this dreadful condition, it is essential to develop more effective medicines. Inhibition of the ubiquitin-proteasome system (UPS) causes pancreatic cancer cells to die apoptotically. In eukaryotes, UPS is an essential mechanism for protein breakdown. Pancreatic cancer cells are more susceptible to endoplasmic reticulum stress (endoplasmic reticulum [ER] stress) and apoptosis when treated with bortezomib, a proteasome inhibitor that is the first in this group of drugs approved for the treatment of cancer, especially multiple myeloma.</p><p><strong>Methods: </strong>Searching through PubMed and Google Scholar and gathering data.</p><p><strong>Results: </strong>UPS is still a popular target for pancreatic cancer treatment among researchers. However, despite the favorable results of UPS-based therapies in vitro and in vivo, the clinical results are not as promising as expected.</p><p><strong>Conclusion: </strong>A deep understanding of it, is essential to achieving the maximum results. In this review, we aim to look into the UPS along with searching for the novelist therapies for pancreatic adenocarcinoma based on manipulating it.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"15 ","pages":"29993"},"PeriodicalIF":2.2,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12204783/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144530512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug self-delivery systems: A comprehensive review on small molecule nanodrugs. 药物自释系统:小分子纳米药物研究综述。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-27 eCollection Date: 2025-01-01 DOI: 10.34172/bi.30161
Mahsa Sayed Tabatabaei, Fakhredin A Sayed Tabatabaei, Hamid Reza Moghimi

Drug self-delivery systems are nanostructures composed of a drug as the main structural unit, having the ability of intracellular trafficking with no additional carrier. In these systems, the drug itself undertakes the functional and structural roles; thereby, the ancillary role of excipients and carrier-related limitations are circumvented and therapeutic effect is achieved at a much lower dose. Such advantages -which are mainly but not exclusively beneficial in cancer treatment- have recently led to an upsurge of research on these systems. Subsequently, various terminologies were utilized to describe them, referring to the same concept with different words. However, not all the systems developed based on the self-delivery approach are introduced using one of these keywords. Using a scoping strategy, this review aims to encompass the systems that have been developed as yet -inspired by the concept of self-delivery- and classify them in a coherent taxonomy. Two main groups are introduced based on the type of building blocks: small molecule-based nanomedicines and self-assembling hybrid prodrugs. Due to the diversity, covering the whole gamut of topics is beyond the scope of a single article, and, inevitably, the latter is just briefly introduced here, whereas the features of the former group are meticulously presented. Depending on whether the drug is merely a carrier for itself or carries a second drug as cargo, two classes of small molecule-based nanomedicines are defined (i.e., pure nanodrugs and carrier-mimicking systems, respectively), each having sub-branches. After introducing each branch and giving some examples, possible strategies for designing each particular system are visually displayed. The resultant mind map can create a macro view of the taken path and its prospects, give a profound insight into opportunities, spark new ideas, and facilitate overcoming obstacles. Taken together, one can foresee a brilliant future for self-delivery systems as a pioneering candidate for the next generation of drug delivery systems.

药物自给系统是一种以药物为主要结构单元的纳米结构,无需额外载体即可实现细胞内运输。在这些系统中,药物本身承担了功能和结构作用,从而避免了辅料的辅助作用和载体的相关限制,并以更低的剂量达到治疗效果。这些优势(主要但不限于癌症治疗)最近引发了对这些系统的研究热潮。随后,人们使用各种术语来描述这些系统,用不同的词来指代相同的概念。然而,并非所有基于自我给药方法开发的系统都使用了其中一个关键词。本综述采用范围界定策略,旨在涵盖受自主交付概念启发而开发的系统,并将其归入一个连贯的分类法。根据构建模块的类型主要分为两类:基于小分子的纳米药物和自组装混合原药。由于种类繁多,一篇文章无法涵盖所有主题,因此这里不可避免地只简要介绍了后者,而对前者的特点则做了细致的介绍。根据药物本身只是载体还是携带第二种药物作为货物,定义了两类基于小分子的纳米药物(分别是纯纳米药物和载体模拟系统),每一类都有分支。在介绍了每个分支并举例说明后,直观地展示了设计每个特定系统的可能策略。由此绘制的思维导图可以从宏观上把握已走过的道路及其前景,深刻洞察机遇,激发新的想法,帮助克服障碍。综上所述,我们可以预见,作为下一代给药系统的先驱,自我给药系统的前景将一片光明。
{"title":"Drug self-delivery systems: A comprehensive review on small molecule nanodrugs.","authors":"Mahsa Sayed Tabatabaei, Fakhredin A Sayed Tabatabaei, Hamid Reza Moghimi","doi":"10.34172/bi.30161","DOIUrl":"10.34172/bi.30161","url":null,"abstract":"<p><p>Drug self-delivery systems are nanostructures composed of a drug as the main structural unit, having the ability of intracellular trafficking with no additional carrier. In these systems, the drug itself undertakes the functional and structural roles; thereby, the ancillary role of excipients and carrier-related limitations are circumvented and therapeutic effect is achieved at a much lower dose. Such advantages -which are mainly but not exclusively beneficial in cancer treatment- have recently led to an upsurge of research on these systems. Subsequently, various terminologies were utilized to describe them, referring to the same concept with different words. However, not all the systems developed based on the self-delivery approach are introduced using one of these keywords. Using a scoping strategy, this review aims to encompass the systems that have been developed as yet -inspired by the concept of self-delivery- and classify them in a coherent taxonomy. Two main groups are introduced based on the type of building blocks: small molecule-based nanomedicines and self-assembling hybrid prodrugs. Due to the diversity, covering the whole gamut of topics is beyond the scope of a single article, and, inevitably, the latter is just briefly introduced here, whereas the features of the former group are meticulously presented. Depending on whether the drug is merely a carrier for itself or carries a second drug as cargo, two classes of small molecule-based nanomedicines are defined (i.e., pure nanodrugs and carrier-mimicking systems, respectively), each having sub-branches. After introducing each branch and giving some examples, possible strategies for designing each particular system are visually displayed. The resultant mind map can create a macro view of the taken path and its prospects, give a profound insight into opportunities, spark new ideas, and facilitate overcoming obstacles. Taken together, one can foresee a brilliant future for self-delivery systems as a pioneering candidate for the next generation of drug delivery systems.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"15 ","pages":"30161"},"PeriodicalIF":2.2,"publicationDate":"2024-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954755/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An update on technical method of cartilage decellularization: A physical-based protocol. 软骨脱细胞技术方法的更新:基于物理的方案。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-26 eCollection Date: 2025-01-01 DOI: 10.34172/bi.2024.30047
Hengameh Dortaj, Ahmad Vaez, Ashraf Hassanpour-Dehnavie, Ali Akbar Alizadeh

Introduction: Despite advances in orthopedic surgery, the lack of effective conventional treatment for cartilage defects has led to research in cartilage tissue engineering. One of the interesting topics is the use of decellularized extracellular matrix (ECM) as a suitable natural scaffold that supports the growth and function of cells cultured in it. A concern with decellularization protocols, especially those with high detergent concentrations, is the disruption of native ECM, which has deleterious effects on subsequent scaffold recellularization. Therefore, this study focused on optimizing cartilage decellularization by physical methods without the use of ionic detergents.

Methods: The bovine tracheal cartilage fragments were decellularized by a combination of 8 cycles of freeze-thaw and ultrasound techniques. Then, the tissues were immersed and shaken in 0.25% trypsin for 24 hours. Efficient cell removal and preservation of ECM were confirmed by histological and cytocompatibility assessments. The in-vivo studies were performed to evaluate the biocompatibility and bioactivity of the scaffold.

Results: The histological assessments indicated the appropriate cytocompatibility and the fibroblast cell culture study demonstrated that cells were able to proliferate and migrate on the decellularized cartilage. In-vivo evaluation also showed a reduced adverse immune response, including leukocyte infiltration into the ECM.

Conclusion: These results suggest that a cartilage scaffold created using a physical decellularization protocol that efficiently removes cells while preserving the native ECM can be a suitable scaffold for cartilage reconstruction. The main advantage of this protocol is the absence of potentially toxic chemicals in the tissues.

导论:尽管骨科手术取得了进步,但缺乏有效的常规治疗软骨缺损的方法,这导致了软骨组织工程的研究。其中一个有趣的话题是使用脱细胞细胞外基质(ECM)作为一种合适的天然支架,支持在其中培养的细胞的生长和功能。脱细胞方案的一个问题,特别是那些高洗涤剂浓度的方案,是对天然ECM的破坏,这对随后的支架再细胞化有有害影响。因此,本研究的重点是在不使用离子洗涤剂的情况下,通过物理方法优化软骨脱细胞。方法:采用8次冻融结合超声技术对牛气管软骨碎片进行脱细胞。然后,将组织浸入0.25%胰蛋白酶中震荡24小时。组织学和细胞相容性评估证实了ECM有效的细胞去除和保存。进行了体内研究,以评估支架的生物相容性和生物活性。结果:组织学评估显示细胞相容性良好,成纤维细胞培养研究表明细胞能够在脱细胞软骨上增殖和迁移。体内评估也显示不良免疫反应减少,包括白细胞浸润到ECM。结论:这些结果表明,使用物理脱细胞方案创建的软骨支架可以有效地去除细胞,同时保留天然ECM,是软骨重建的合适支架。该方案的主要优点是组织中没有潜在的有毒化学物质。
{"title":"An update on technical method of cartilage decellularization: A physical-based protocol.","authors":"Hengameh Dortaj, Ahmad Vaez, Ashraf Hassanpour-Dehnavie, Ali Akbar Alizadeh","doi":"10.34172/bi.2024.30047","DOIUrl":"10.34172/bi.2024.30047","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>Despite advances in orthopedic surgery, the lack of effective conventional treatment for cartilage defects has led to research in cartilage tissue engineering. One of the interesting topics is the use of decellularized extracellular matrix (ECM) as a suitable natural scaffold that supports the growth and function of cells cultured in it. A concern with decellularization protocols, especially those with high detergent concentrations, is the disruption of native ECM, which has deleterious effects on subsequent scaffold recellularization. Therefore, this study focused on optimizing cartilage decellularization by physical methods without the use of ionic detergents.</p><p><strong>Methods: </strong>The bovine tracheal cartilage fragments were decellularized by a combination of 8 cycles of freeze-thaw and ultrasound techniques. Then, the tissues were immersed and shaken in 0.25% trypsin for 24 hours. Efficient cell removal and preservation of ECM were confirmed by histological and cytocompatibility assessments. The in-vivo studies were performed to evaluate the biocompatibility and bioactivity of the scaffold.</p><p><strong>Results: </strong>The histological assessments indicated the appropriate cytocompatibility and the fibroblast cell culture study demonstrated that cells were able to proliferate and migrate on the decellularized cartilage. In-vivo evaluation also showed a reduced adverse immune response, including leukocyte infiltration into the ECM.</p><p><strong>Conclusion: </strong>These results suggest that a cartilage scaffold created using a physical decellularization protocol that efficiently removes cells while preserving the native ECM can be a suitable scaffold for cartilage reconstruction. The main advantage of this protocol is the absence of potentially toxic chemicals in the tissues.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"15 ","pages":"30047"},"PeriodicalIF":2.2,"publicationDate":"2024-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bibliometric study of BioImpacts using a technological impact approach. 使用技术影响方法对生物影响进行文献计量学研究。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-08 eCollection Date: 2025-01-01 DOI: 10.34172/bi.30401
Leila Mirzapour, Fatemeh Sheikhshoaei

Introduction: The number of citations received by articles is a key indicator of a journal's quality and effectiveness within its field. This, in turn, influences the ability to secure funding for ongoing publication, establishing a suitable policy for its promotion, and helping researchers selecting an appropriate journal to publish their findings or find information they require. Meanwhile, one way to measure a journal's technological impact is to examine the patent citations attached to its articles. This study aims to evaluate the technological impact of BioImpacts (BI) by examining the patents' citations to its articles.

Methods: This descriptive study was conducted using the bibliometric method with a technological impact approach. The published BI belonged to the years 2011-2023. Data were extracted using the Lens and Espacenet databases. Descriptive statistics and Excel software were applied for data analysis.

Results: The results revealed that BI had a 10% technological impact. Original research contributed to most of the cited articles (27). American patents were the most impacted by BI's articles. Moreover, human necessities (A) and chemistry and metallurgy (C) were two main technological sections influenced by BI's articles. The most active and influential country was Iran and the most active and influential organization was Tabriz University of Medical Sciences.

Conclusion: Based on the present research findings, the technological impact of BI is considerable; so, it is important to present information about this issue on the journal's website and adopt appropriate policies for further development of BI in this field.

文章被引用的次数是期刊在其领域内的质量和有效性的关键指标。这反过来又影响了为正在进行的发表获得资金、为其推广建立合适的政策以及帮助研究人员选择合适的期刊来发表他们的发现或找到他们需要的信息的能力。与此同时,衡量期刊技术影响力的一种方法是检查其文章附带的专利引用。本研究旨在通过检查BioImpacts (BI)的专利对其文章的引用来评估其技术影响。方法:采用文献计量学方法和技术影响法进行描述性研究。公布的BI属于2011-2023年。使用Lens和Espacenet数据库提取数据。采用描述性统计和Excel软件进行数据分析。结果:结果显示,BI具有10%的技术影响。原创性研究贡献了大部分被引文章(27)。美国专利受BI文章影响最大。此外,人类必需品(A)和化学冶金(C)是受BI文章影响的两个主要技术领域。最活跃和最有影响力的国家是伊朗,最活跃和最有影响力的组织是大不里士医科大学。结论:基于目前的研究成果,BI的技术影响是相当大的;因此,重要的是在期刊的网站上提供有关该问题的信息,并为该领域的BI进一步发展采取适当的政策。
{"title":"Bibliometric study of <i>BioImpacts</i> using a technological impact approach.","authors":"Leila Mirzapour, Fatemeh Sheikhshoaei","doi":"10.34172/bi.30401","DOIUrl":"https://doi.org/10.34172/bi.30401","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>The number of citations received by articles is a key indicator of a journal's quality and effectiveness within its field. This, in turn, influences the ability to secure funding for ongoing publication, establishing a suitable policy for its promotion, and helping researchers selecting an appropriate journal to publish their findings or find information they require. Meanwhile, one way to measure a journal's technological impact is to examine the patent citations attached to its articles. This study aims to evaluate the technological impact of <i>BioImpacts (BI)</i> by examining the patents' citations to its articles.</p><p><strong>Methods: </strong>This descriptive study was conducted using the bibliometric method with a technological impact approach. The published <i>BI</i> belonged to the years 2011-2023. Data were extracted using the Lens and Espacenet databases. Descriptive statistics and Excel software were applied for data analysis.</p><p><strong>Results: </strong>The results revealed that <i>BI</i> had a 10% technological impact. Original research contributed to most of the cited articles (27). American patents were the most impacted by <i>BI'</i>s articles. Moreover, human necessities (A) and chemistry and metallurgy (C) were two main technological sections influenced by <i>BI'</i>s articles. The most active and influential country was Iran and the most active and influential organization was Tabriz University of Medical Sciences.</p><p><strong>Conclusion: </strong>Based on the present research findings, the technological impact of <i>BI</i> is considerable; so, it is important to present information about this issue on the journal's website and adopt appropriate policies for further development of <i>BI</i> in this field.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"15 ","pages":"30401"},"PeriodicalIF":2.2,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12008250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144007302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The synergistic impact of sleep duration and obesity on metabolic syndrome risk: exploring the role of microRNAs. 睡眠时间和肥胖对代谢综合征风险的协同影响:探索microrna的作用。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-02 eCollection Date: 2025-01-01 DOI: 10.34172/bi.30593
Atefeh Ansarin, Dariush Shanehbandi, Habib Zarredar, Alireza Ostadrahimi, Neda Gilani, Khalil Ansarin

Introduction: Given the well-established association between metabolic syndrome (MetS) and obesity, this study elucidates the influences of sleep duration and weight on MetS risk and explores the potential role of miRNAs as underlying mechanisms.

Methods: According to sleep logs and biochemistry tests, this study investigated the association between MetS and its components, sleep duration, and weight in four subgroups: A: normal sleepers with normal weight (N = 145), B: normal sleepers with obesity (N = 140), C: short sleepers with normal weight (N = 130), and D: short sleepers with obesity (N = 142). Chi-square, one-way ANOVA, and Tukey's post hoc tests were used for statistical analysis. Furthermore, following total RNA isolation by TRIzol from blood samples, cDNA was synthesized using stem-loop technique. Quantitative real-time polymerase chain reaction (qRT-PCR) was then employed to evaluate the expression levels of miR-33a, miR-378a, miR-132-3p, and miR-181d. The data were analyzed using one-way ANOVA.

Results: Our findings revealed the strongest association between MetS prevalence and individuals in group D (short sleepers with obesity; Cramer's V = 0.649, P < 0.001). This observation underscores the synergistic effect of short sleep and obesity on MetS risk. Furthermore, there was an independent association between short sleep duration and elevated triglyceride levels (P < 0.05). MicroRNA expression analysis revealed downregulation of miR-33a and miR-181d in B, C, and D groups compared to the normal group. Conversely, miR-132-3p expression was upregulated in the B, C, and D groups.

Conclusion: Short sleep and obesity synergistically elevate MetS risk, potentially via miR-33a and miR-181d downregulation and miR-132-3p upregulation, impacting triglyceride metabolism.

导论:鉴于代谢综合征(MetS)与肥胖之间已经建立了良好的联系,本研究阐明了睡眠时间和体重对MetS风险的影响,并探讨了mirna作为潜在机制的潜在作用。方法:根据睡眠记录和生物化学测试,研究了4个亚组:A:正常体重的正常睡眠者(N = 145), B:肥胖的正常睡眠者(N = 140), C:正常体重的短睡眠者(N = 130), D:肥胖的短睡眠者(N = 142)。采用卡方检验、单因素方差分析和Tukey事后检验进行统计分析。此外,用TRIzol从血样中分离总RNA后,利用茎环技术合成cDNA。然后采用实时定量聚合酶链反应(qRT-PCR)评估miR-33a、miR-378a、miR-132-3p和miR-181d的表达水平。数据采用单因素方差分析。结果:我们的研究结果揭示了met患病率与D组(肥胖的短睡者;结论:短睡眠和肥胖协同提高MetS风险,可能是通过miR-33a和miR-181d下调和miR-132-3p上调,影响甘油三酯代谢。
{"title":"The synergistic impact of sleep duration and obesity on metabolic syndrome risk: exploring the role of microRNAs.","authors":"Atefeh Ansarin, Dariush Shanehbandi, Habib Zarredar, Alireza Ostadrahimi, Neda Gilani, Khalil Ansarin","doi":"10.34172/bi.30593","DOIUrl":"https://doi.org/10.34172/bi.30593","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>Given the well-established association between metabolic syndrome (MetS) and obesity, this study elucidates the influences of sleep duration and weight on MetS risk and explores the potential role of miRNAs as underlying mechanisms.</p><p><strong>Methods: </strong>According to sleep logs and biochemistry tests, this study investigated the association between MetS and its components, sleep duration, and weight in four subgroups: A: normal sleepers with normal weight (N = 145), B: normal sleepers with obesity (N = 140), C: short sleepers with normal weight (N = 130), and D: short sleepers with obesity (N = 142). Chi-square, one-way ANOVA, and Tukey's post hoc tests were used for statistical analysis. Furthermore, following total RNA isolation by TRIzol from blood samples, cDNA was synthesized using stem-loop technique. Quantitative real-time polymerase chain reaction (qRT-PCR) was then employed to evaluate the expression levels of miR-33a, miR-378a, miR-132-3p, and miR-181d. The data were analyzed using one-way ANOVA.</p><p><strong>Results: </strong>Our findings revealed the strongest association between MetS prevalence and individuals in group D (short sleepers with obesity; Cramer's V = 0.649, <i>P</i> < 0.001). This observation underscores the synergistic effect of short sleep and obesity on MetS risk. Furthermore, there was an independent association between short sleep duration and elevated triglyceride levels (<i>P</i> < 0.05). MicroRNA expression analysis revealed downregulation of miR-33a and miR-181d in B, C, and D groups compared to the normal group. Conversely, miR-132-3p expression was upregulated in the B, C, and D groups.</p><p><strong>Conclusion: </strong>Short sleep and obesity synergistically elevate MetS risk, potentially via miR-33a and miR-181d downregulation and miR-132-3p upregulation, impacting triglyceride metabolism.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"15 ","pages":"30593"},"PeriodicalIF":2.2,"publicationDate":"2024-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12008491/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144057812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An efficient hybrid filter-wrapper method based on improved Harris Hawks optimization for feature selection. 基于改进Harris Hawks优化的混合滤波包装方法用于特征选择。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-01 eCollection Date: 2025-01-01 DOI: 10.34172/bi.30340
Jamshid Pirgazi, Mohammad Mehdi Pourhashem Kallehbasti, Ali Ghanbari Sorkhi, Ali Kermani

Introduction: High-dimensional datasets often contain an abundance of features, many of which are irrelevant to the subject of interest. This issue is compounded by the frequently low number of samples and imbalanced class samples. These factors can negatively impact the performance of classification algorithms, necessitating feature selection before classification. The primary objective of feature selection algorithms is to identify a minimal subset of features that enables accurate classification.

Methods: In this paper, we propose a two-stage hybrid method for the optimal selection of relevant features. In the first stage, a filter method is employed to assign weights to the features, facilitating the removal of redundant and irrelevant features and reducing the computational cost of classification algorithms. A subset of high-weight features is retained for further processing in the second stage. In this stage, an enhanced Harris Hawks Optimization algorithm and GRASP, augmented with crossover and mutation operators from genetic algorithms, are utilized based on the weights calculated in the first stage to identify the optimal feature set.

Results: Experimental results demonstrate that the proposed algorithm successfully identifies the optimal subset of features.

Conclusion: The two-stage hybrid method effectively selects the optimal subset of features, improving the performance of classification algorithms on high-dimensional datasets. This approach addresses the challenges posed by the abundance of features, low number of samples, and imbalanced class samples, demonstrating its potential for application in various fields.

高维数据集通常包含大量的特征,其中许多与感兴趣的主题无关。这个问题由于样本数量经常较少和类别样本不平衡而变得更加复杂。这些因素会对分类算法的性能产生负面影响,因此需要在分类前进行特征选择。特征选择算法的主要目标是识别能够进行准确分类的最小特征子集。方法:本文提出了一种两阶段混合方法来优化相关特征的选择。在第一阶段,采用滤波方法对特征进行权重分配,有利于去除冗余和不相关的特征,降低分类算法的计算成本。保留高权重特征的子集以便在第二阶段进行进一步处理。在此阶段,基于第一阶段计算的权重,利用增强型Harris Hawks优化算法和GRASP,并加入遗传算法的交叉和突变算子,来识别最优特征集。结果:实验结果表明,该算法成功地识别出了最优特征子集。结论:两阶段混合方法有效地选择了最优的特征子集,提高了分类算法在高维数据集上的性能。该方法解决了特征丰富、样本数量少、类别样本不平衡等问题,展示了其在各个领域的应用潜力。
{"title":"An efficient hybrid filter-wrapper method based on improved Harris Hawks optimization for feature selection.","authors":"Jamshid Pirgazi, Mohammad Mehdi Pourhashem Kallehbasti, Ali Ghanbari Sorkhi, Ali Kermani","doi":"10.34172/bi.30340","DOIUrl":"https://doi.org/10.34172/bi.30340","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>High-dimensional datasets often contain an abundance of features, many of which are irrelevant to the subject of interest. This issue is compounded by the frequently low number of samples and imbalanced class samples. These factors can negatively impact the performance of classification algorithms, necessitating feature selection before classification. The primary objective of feature selection algorithms is to identify a minimal subset of features that enables accurate classification.</p><p><strong>Methods: </strong>In this paper, we propose a two-stage hybrid method for the optimal selection of relevant features. In the first stage, a filter method is employed to assign weights to the features, facilitating the removal of redundant and irrelevant features and reducing the computational cost of classification algorithms. A subset of high-weight features is retained for further processing in the second stage. In this stage, an enhanced Harris Hawks Optimization algorithm and GRASP, augmented with crossover and mutation operators from genetic algorithms, are utilized based on the weights calculated in the first stage to identify the optimal feature set.</p><p><strong>Results: </strong>Experimental results demonstrate that the proposed algorithm successfully identifies the optimal subset of features.</p><p><strong>Conclusion: </strong>The two-stage hybrid method effectively selects the optimal subset of features, improving the performance of classification algorithms on high-dimensional datasets. This approach addresses the challenges posed by the abundance of features, low number of samples, and imbalanced class samples, demonstrating its potential for application in various fields.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"15 ","pages":"30340"},"PeriodicalIF":2.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12008497/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144021513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the function and targeting of MET protein as an oncogene kinase in pancreatic ductal adenocarcinoma: A microarray data integration. 研究MET蛋白作为癌基因激酶在胰腺导管腺癌中的功能和靶向性:微阵列数据集成。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-10-01 eCollection Date: 2025-01-01 DOI: 10.34172/bi.30187
Nahid Askari, Morteza Hadizadeh, Mohammad Sina, Sepideh Parvizpour, Seyedeh Zahra Mousavi, Mohd Shahir Shamsir

Introduction: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with a poor prognosis. Kinase proteins are essential regulators of cellular processes and potential targets for drug development.

Methods: Integration of multiple microarray datasets was screened to find differentially expressed kinases (DE-Kinases) across adjacent normal and tumor tissue samples in PDAC. The most effective kinase for drug design and docking in this study was selected by investigating biological mechanisms and survival analyses. Forty phytochemicals were extracted from the yellow sweet clover, Melilotus officinalis (Linn.) Pall, and were then subjected to in silico screening and molecular docking studies against a specific potent kinase.

Results: MET, PAK3, and PDK4 were identified as the DE-Kinases. After examining the pathways and biological processes, up-regulated MET had the most significant survival analysis and became our primary kinase for drug design and docking in this study. Four of the extracted phytocompounds of Melilotus officinalis (Linn.) Pall that exhibited high binding affinities with MET and were selected for toxicity analysis. Finally, the stability and mobility of the two nontoxic compounds that passed the toxicity test (dicumarol PubChem CID: 54676038 and melilotigenin PubChem CID: 14059499) were studied by molecular dynamics simulation.

Conclusion: This study's results identified two phytochemicals in yellow sweet clover that could be used to develop an anticancer drug, but experimental evaluation is necessary to confirm their efficacy.

简介:胰腺导管腺癌(Pancreatic ductal adencarcinoma, PDAC)是一种预后不良的高致死率疾病。激酶蛋白是细胞过程的重要调节因子,也是药物开发的潜在靶点。方法:整合多个微阵列数据集筛选PDAC邻近正常和肿瘤组织样本中的差异表达激酶(de -激酶)。通过研究生物学机制和生存期分析,选择了本研究中最有效的药物设计和对接激酶。从黄甜三叶草Melilotus officinalis (Linn.)中提取了40种植物化学物质。然后进行硅筛选和针对特定强效激酶的分子对接研究。结果:鉴定出MET、PAK3、PDK4为de -激酶。在检查了途径和生物学过程后,上调的MET具有最显著的生存分析,并成为本研究中药物设计和对接的主要激酶。木犀草(Linn.)提取的四种植物化合物与MET具有高结合亲和力的Pall被选中进行毒性分析。最后,通过分子动力学模拟研究了通过毒性试验的两种无毒化合物(双豆醇PubChem CID: 54676038和melilotigenin PubChem CID: 14059499)的稳定性和迁移性。结论:本研究发现黄甜三叶草中含有两种可用于开发抗癌药物的植物化学物质,但其药效有待实验验证。
{"title":"Investigating the function and targeting of MET protein as an oncogene kinase in pancreatic ductal adenocarcinoma: A microarray data integration.","authors":"Nahid Askari, Morteza Hadizadeh, Mohammad Sina, Sepideh Parvizpour, Seyedeh Zahra Mousavi, Mohd Shahir Shamsir","doi":"10.34172/bi.30187","DOIUrl":"10.34172/bi.30187","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with a poor prognosis. Kinase proteins are essential regulators of cellular processes and potential targets for drug development.</p><p><strong>Methods: </strong>Integration of multiple microarray datasets was screened to find differentially expressed kinases (DE-Kinases) across adjacent normal and tumor tissue samples in PDAC. The most effective kinase for drug design and docking in this study was selected by investigating biological mechanisms and survival analyses. Forty phytochemicals were extracted from the yellow sweet clover, <i>Melilotus officinalis</i> (Linn.) Pall, and were then subjected to in silico screening and molecular docking studies against a specific potent kinase.</p><p><strong>Results: </strong>MET, PAK3, and PDK4 were identified as the DE-Kinases. After examining the pathways and biological processes, up-regulated MET had the most significant survival analysis and became our primary kinase for drug design and docking in this study. Four of the extracted phytocompounds of <i>Melilotus officinalis</i> (Linn.) Pall that exhibited high binding affinities with MET and were selected for toxicity analysis. Finally, the stability and mobility of the two nontoxic compounds that passed the toxicity test (dicumarol PubChem CID: 54676038 and melilotigenin PubChem CID: 14059499) were studied by molecular dynamics simulation.</p><p><strong>Conclusion: </strong>This study's results identified two phytochemicals in yellow sweet clover that could be used to develop an anticancer drug, but experimental evaluation is necessary to confirm their efficacy.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"15 ","pages":"30187"},"PeriodicalIF":2.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954745/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of extracellular vesicles in individuals with cancer; A systematic review. 细胞外囊泡治疗癌症患者的安全性和有效性系统回顾。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-29 eCollection Date: 2025-01-01 DOI: 10.34172/bi.30501
Hila Asham, Negin Jafari, Elham Mohamadrezapour, Hossein Bannazadeh Baghi, Hosein Eslami, Taher Entezari-Maleki

Introduction: Extracellular vesicles (EVs) are crucial in intercellular signaling pathways. Since cancer has had a significant impact on global health as the second leading cause of death, this study aimed to systematically review the literature on the efficacy and safety of EVs in this setting.

Methods: A systematic literature review was performed on MEDLINE, Embase, the Cochrane Library, and ClinicalTrials.gov from database inception until August 10th, 2023. Based on PICOS, the inclusion criteria were: individuals with cancer treated with EVs compared to control among clinical studies.

Results: EVs administered to 46 individuals with cancer. Most studies revealed significant clinical benefits after treatment. Results also demonstrated that EVs are safe without major adverse events (AEs).

Conclusion: The use of EVs may provide potential therapeutic benefits for treating cancer. Further, well-designed randomized clinical trials (RCTs) are needed to provide robust evidence for supporting the clinical use of EVs in this setting.

细胞外囊泡(EVs)在细胞间信号通路中起着至关重要的作用。由于癌症作为第二大死亡原因对全球健康产生了重大影响,本研究旨在系统地回顾关于电动汽车在这种情况下的有效性和安全性的文献。方法:系统回顾MEDLINE、Embase、Cochrane Library和ClinicalTrials.gov从数据库建立到2023年8月10日的文献。基于PICOS,纳入标准是:与临床研究中的对照组相比,接受ev治疗的癌症患者。结果:46例癌症患者接受了ev治疗。大多数研究显示治疗后显著的临床益处。结果还表明,电动汽车是安全的,没有重大不良事件(ae)。结论:EVs在肿瘤治疗中具有潜在的疗效。此外,需要精心设计的随机临床试验(rct),为支持电动汽车在这种情况下的临床使用提供强有力的证据。
{"title":"Safety and efficacy of extracellular vesicles in individuals with cancer; A systematic review.","authors":"Hila Asham, Negin Jafari, Elham Mohamadrezapour, Hossein Bannazadeh Baghi, Hosein Eslami, Taher Entezari-Maleki","doi":"10.34172/bi.30501","DOIUrl":"https://doi.org/10.34172/bi.30501","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>Extracellular vesicles (EVs) are crucial in intercellular signaling pathways. Since cancer has had a significant impact on global health as the second leading cause of death, this study aimed to systematically review the literature on the efficacy and safety of EVs in this setting.</p><p><strong>Methods: </strong>A systematic literature review was performed on MEDLINE, Embase, the Cochrane Library, and ClinicalTrials.gov from database inception until August 10th, 2023. Based on PICOS, the inclusion criteria were: individuals with cancer treated with EVs compared to control among clinical studies.</p><p><strong>Results: </strong>EVs administered to 46 individuals with cancer. Most studies revealed significant clinical benefits after treatment. Results also demonstrated that EVs are safe without major adverse events (AEs).</p><p><strong>Conclusion: </strong>The use of EVs may provide potential therapeutic benefits for treating cancer. Further, well-designed randomized clinical trials (RCTs) are needed to provide robust evidence for supporting the clinical use of EVs in this setting.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"15 ","pages":"30501"},"PeriodicalIF":2.2,"publicationDate":"2024-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12008492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144035401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automatic classification of Giardia infection from stool microscopic images using deep neural networks. 基于深度神经网络的粪便显微图像贾第虫感染自动分类。
IF 2.2 4区 工程技术 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2024-09-24 eCollection Date: 2025-01-01 DOI: 10.34172/bi.30272
Pezhman Yarahmadi, Ehsan Ahmadpour, Parham Moradi, Nasser Samadzadehaghdam

Introduction: Giardiasis is a common intestinal infection caused by the Giardia lamblia parasite, and its rapid and accurate diagnosis is crucial for effective treatment. The automatic classification of Giardia infection from stool microscopic images plays a vital role in this diagnosis process. In this study, we applied deep learning-based models to automatically classify stool microscopic images into three categories, namely, normal, cyst, and trophozoite.

Methods: Unlike previous studies focused on images acquired from drinking water samples, we specifically targeted stool samples. In this regard, we collected a dataset of 1610 microscopic digital images captured by a smartphone with a resolution of 2340 × 1080 pixels from stool samples under the Nikon YS100 microscope. First, we applied CLAHE (Contrast Limited Adaptive Histogram Equalization) histogram equalization a method to enhance the image quality and contrast. We employed three deep learning models, namely Xception, ResNet-50, and EfficientNet-B0, to evaluate their classification performance. Each model was trained on the dataset of microscopic images and fine-tuned using transfer learning techniques.

Results: Among the three deep learning models, EfficientNet-B0 demonstrated superior performance in classifying Giardia lamblia parasites from stool microscopic images. The model achieved precision, accuracy, recall, specificity, and F1-score values of 0.9599, 0.9629, 0.9619, 0.9821, and 0.9607, respectively.

Conclusion: The EfficientNet-B0 showed promising results in accurately identifying normal, cyst, and trophozoite forms of Giardia lamblia parasites. This automated classification approach can provide valuable assistance to laboratory science experts and parasitologists in the rapid and accurate diagnosis of giardiasis, ultimately improving patient care and treatment outcomes.

导言:贾第虫病是一种由蓝氏贾第虫引起的常见肠道传染病,快速准确的诊断对有效治疗至关重要。从粪便显微图像中自动分类贾第虫感染在诊断过程中起着至关重要的作用。在本研究中,我们应用基于深度学习的模型将粪便显微图像自动分为三类,即正常、囊肿和滋养体:与以往侧重于从饮用水样本中获取图像的研究不同,我们特别针对粪便样本进行了研究。为此,我们在尼康 YS100 显微镜下收集了由智能手机拍摄的 1610 张显微数字图像数据集,分辨率为 2340 × 1080 像素。首先,我们应用了 CLAHE(对比度受限自适应直方图均衡化)直方图均衡化方法来提高图像质量和对比度。我们采用了三种深度学习模型,即 Xception、ResNet-50 和 EfficientNet-B0,来评估它们的分类性能。每个模型都在显微图像数据集上进行了训练,并使用迁移学习技术进行了微调:在这三种深度学习模型中,EfficientNet-B0 在对粪便显微图像中的贾第鞭毛虫寄生虫进行分类方面表现优异。该模型的精确度、准确度、召回率、特异性和 F1 分数分别达到了 0.9599、0.9629、0.9619、0.9821 和 0.9607:EfficientNet-B0在准确识别正常、囊肿和滋养体形式的蓝氏贾第鞭毛虫寄生虫方面显示出良好的效果。这种自动分类方法可以为实验室科学专家和寄生虫学家快速准确地诊断贾第虫病提供有价值的帮助,最终改善患者护理和治疗效果。
{"title":"Automatic classification of <i>Giardia</i> infection from stool microscopic images using deep neural networks.","authors":"Pezhman Yarahmadi, Ehsan Ahmadpour, Parham Moradi, Nasser Samadzadehaghdam","doi":"10.34172/bi.30272","DOIUrl":"10.34172/bi.30272","url":null,"abstract":"<p><p></p><p><strong>Introduction: </strong>Giardiasis is a common intestinal infection caused by the <i>Giardia</i> lamblia parasite, and its rapid and accurate diagnosis is crucial for effective treatment. The automatic classification of <i>Giardia</i> infection from stool microscopic images plays a vital role in this diagnosis process. In this study, we applied deep learning-based models to automatically classify stool microscopic images into three categories, namely, normal, cyst, and trophozoite.</p><p><strong>Methods: </strong>Unlike previous studies focused on images acquired from drinking water samples, we specifically targeted stool samples. In this regard, we collected a dataset of 1610 microscopic digital images captured by a smartphone with a resolution of 2340 × 1080 pixels from stool samples under the Nikon YS100 microscope. First, we applied CLAHE (Contrast Limited Adaptive Histogram Equalization) histogram equalization a method to enhance the image quality and contrast. We employed three deep learning models, namely Xception, ResNet-50, and EfficientNet-B0, to evaluate their classification performance. Each model was trained on the dataset of microscopic images and fine-tuned using transfer learning techniques.</p><p><strong>Results: </strong>Among the three deep learning models, EfficientNet-B0 demonstrated superior performance in classifying <i>Giardia</i> lamblia parasites from stool microscopic images. The model achieved precision, accuracy, recall, specificity, and F1-score values of 0.9599, 0.9629, 0.9619, 0.9821, and 0.9607, respectively.</p><p><strong>Conclusion: </strong>The EfficientNet-B0 showed promising results in accurately identifying normal, cyst, and trophozoite forms of <i>Giardia</i> lamblia parasites. This automated classification approach can provide valuable assistance to laboratory science experts and parasitologists in the rapid and accurate diagnosis of giardiasis, ultimately improving patient care and treatment outcomes.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"15 ","pages":"30272"},"PeriodicalIF":2.2,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11954735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bioimpacts
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1